Skip to main content

Arthrex Accused Of False Marketing Recalled Knee System

Arthrex Accused Of False Marketing Recalled Knee System

Arthrex Accused Of False Marketing Recalled Knee System

Introduction

In an August 8 complaint filed in the U.S. District Court District of Pennsylvania, a plaintiff alleges that Arthrex Inc.’s recalled iBalance knee replacement device, he was implanted with, was faulty and required him to undergo a revision surgery. The plaintiff blames the company for conducting inadequate testing before exclusively marketing the device. The device was recalled in February 2015, when Arthrex sent out urgent medical device voluntary recall letters to distributors, surgeons, and medical centers, reporting the removal.


More than 4 million Americans have undergone a knee replacement, and thousands have reported faulty device designs. Around 2,378 Arthrex iBalance units were affected by the 2015 FDA Class II recall.  DePuy Synthes Attune, Zimmer, and several other manufacturers are facing claims over faulty knee replacement systems causing severe internal injuries to patients.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!